EUVIMEDEUVIMED entdecken
Open Access

Metabolic Activation‐Dependent Anti‐Liver Cancer Activity and Organ‐Specific Toxicity of Retrorsine From Fanhuncao ( Jacobaea cannabifolia and J. litvinovii )

Zhijie He iD, Zhongyu Tan, Lunrong Zhang, Yue Yin, Yedeli Yerjiang, Bo Bi, Jingshan Bao

Archiv der Pharmazie · 2026-09 · 359 (9)

DOI: 10.1002/ardp.70326 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, online erschienen am 07.09.2026. Verfasst von Zhijie He und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Changchun University of Chinese Medicine, Changchun, Jilin, China. Hauptthemen laut MEDLINE: Pyrrolizidine Alkaloids, Liver Neoplasms, Antineoplastic Agents, Phytogenic, Asteraceae. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Key Research and Development Program of Jilin Provincial Science and Technology Department, Science and Technology Research Project of Jilin Provincial Department of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fanhuncao ( Jacobaea cannabifolia and J. litvinovii ) is a traditional Chinese herb with reported antitumor potential. Retrorsine, a pyrrolizidine alkaloid from Fanhuncao, requires CYP3A4‑mediated metabolic activation, but its dual outcomes (anti‑liver cancer efficacy vs. organ‑specific toxicity) remain unclear. To elucidate how CYP3A4‐dependent activation of retrorsine drives both anti‐liver cancer activity and organ‐specific toxicity, and to identify differential cell death pathways in target organs. UPLC‐HRMS profiled pyrrolizidine alkaloids in Fanhuncao. Cytotoxicity screening, molecular docking, and molecular dynamics identified retrorsine as the lead compound. Network pharmacology/toxicology predicted targets of dehydro‐retrorsine. In vitro assays and Western blotting were performed on hepatoma cells. In vivo efficacy and toxicity were evaluated in H22 tumor‐bearing mice. Retrorsine achieved significant tumor growth inhibition at high dose. Mechanistically, it simultaneously inhibited EGFR/PI3K/AKT/mTOR and NF‐κB pathways while activating intrinsic mitochondrial apoptosis (altered Bax/Bcl‐2, cytochrome c release, Caspase‐9/3 activation). Retrorsine upregulated CYP3A4 in tumor cells, suggesting a potential self‑amplifying metabolic loop that requires further validation. However, this efficacy was accompanied by dose‐dependent hepatorenal toxicity with organ‐specific mechanisms: liver injury via oxidative stress and mitochondrial apoptosis; kidney injury via Caspase‐3/GSDME‐dependent pyroptosis. Retrorsine is a potent multi‐target anti‐liver cancer natural product, but its therapeutic window is narrowed by inseparable organ‐specific toxicities (hepatic apoptosis vs. renal pyroptosis) arising from CYP3A4‐dependent metabolic activation. Future decoupling strategies should focus on targeted delivery, structural modification, or combination therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pyrrolizidine AlkaloidsLiver NeoplasmsAntineoplastic Agents, PhytogenicAsteraceaeAnimalsHumansMiceCytochrome P-450 CYP3AApoptosisActivation, MetabolicMolecular Docking SimulationMolecular StructureCell ProliferationStructure-Activity RelationshipDose-Response Relationship, DrugMaleDrug Screening Assays, AntitumorCell Line, Tumor

Stichwörter der Autor:innen

Fanhuncao (Jacobaea cannabifolia and J. litvinovii)hepatotoxicityliver cancerpyrrolizidine alkaloidretrorsine

Substanzen

Pyrrolizidine AlkaloidsretrorsineAntineoplastic Agents, PhytogenicCytochrome P-450 CYP3ACYP3A4 protein, human

Autor:innen und Institutionen

  • School of Pharmacy, Changchun University of Chinese Medicine, Changchun, Jilin, China.
  • College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, Jilin, China.
  • School of Clinical Medicine, Changchun University of Chinese Medicine, Changchun, Jilin, China.
  • School of Acupuncture and Tuina, Changchun University of Chinese Medicine, Changchun, Jilin, China.

ORCID-Profile: Zhijie He

Förderung

  • Key Research and Development Program of Jilin Provincial Science and Technology Department
  • Science and Technology Research Project of Jilin Provincial Department of Education

Zitieren

APA

He, Z., Tan, Z., Zhang, L., Yin, Y., Yerjiang, Y., Bi, B., & Bao, J. (2026). Metabolic Activation‐Dependent Anti‐Liver Cancer Activity and Organ‐Specific Toxicity of Retrorsine From Fanhuncao ( Jacobaea cannabifolia and J. litvinovii ). Archiv der Pharmazie, 359(9). https://doi.org/10.1002/ardp.70326

Vancouver

He Z, Tan Z, Zhang L, Yin Y, Yerjiang Y, Bi B, et al. Metabolic Activation‐Dependent Anti‐Liver Cancer Activity and Organ‐Specific Toxicity of Retrorsine From Fanhuncao ( Jacobaea cannabifolia and J. litvinovii ). Archiv der Pharmazie. 2026;359(9). doi:10.1002/ardp.70326

BibTeX
@article{He2026,
  author = {He, Zhijie and Tan, Zhongyu and Zhang, Lunrong and Yin, Yue and Yerjiang, Yedeli and Bi, Bo and Bao, Jingshan},
  title = {Metabolic Activation‐Dependent Anti‐Liver Cancer Activity and Organ‐Specific Toxicity of Retrorsine From Fanhuncao ( Jacobaea cannabifolia and J. litvinovii )},
  journal = {Archiv der Pharmazie},
  year = {2026},
  volume = {359},
  number = {9},
  doi = {10.1002/ardp.70326}
}
Kostenlos starten →